78 results
Keyword Sitagliptin Remove keyword
-
List item
Sitagliptin product-specific bioequivalence guidance
Last updated: 01/11/2016Sitagliptin product-specific bioequivalence … Sitagliptin product-specific bioequivalence …
-
List item
National expert: Ilias Migdalis, National Organization for Medicines (updated)
- Declaration of interests - 82.46 KB | PDF
- Curriculum Vitae - 72.53 KB | PDF
board from MSD, concernig sitagliptin(15/2/16) Honarium for my participation … board from MSD, concerning sitagliptin(14/12/16) Honariuum,,speaker,satellite … -
List item
National expert: Angela Garau, Italian Medicines Agency (updated)
- Declaration of interests - 78.9 KB | PDF
- Curriculum Vitae - 84.14 KB | PDF
-
List item
National expert: Ursula Wippo, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 78.93 KB | PDF
- Curriculum Vitae - 74.59 KB | PDF
Rapp/CoRapp): - Janumet (sitagliptin+ metformin) - Ondero (linagliptin … -
List item
National expert: Daniela Melchiorri, Italian Medicines Agency (updated)
- Declaration of interests - 80.6 KB | PDF
- Curriculum Vitae - 97.78 KB | PDF
effectiveness of exenatide, sitagliptin, and vildagliptin for type … -
List item
Product-specific bioequivalence guidance
Last updated: 06/10/2015 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 27/11/2020 -
List item
PRAC recommendations on safety signals (updated)
Last updated: 23/11/2020 -
List item
PDCO: Agendas, minutes and meeting reports (updated)
Last updated: 11/11/2020 -
List item
Article 5(3) opinions
Last updated: 30/09/2020 -
List item
Newsletters (updated)
Last updated: 11/11/2020 -
List item
Medicines under evaluation
Last updated: 16/03/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 March 2018
European Medicines Agency, London, UK, from 05/03/2018 to 08/03/2018, Last updated: 05/03/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 March 2018
European Medicines Agency, London, UK, from 19/03/2018 to 22/03/2018, Last updated: 31/05/2018 -
List item
Annual reports and work programmes
Last updated: 15/06/2020 -
List item
Paediatric Committee (PDCO): 20-22 May 2015
European Medicines Agency, London, UK, from 20/05/2015 to 22/05/2015, Last updated: 20/05/2015 -
List item
PRAC recommendations on safety signals: monthly overviews: Archive
Last updated: 30/05/2017 -
List item
Paediatric Committee (PDCO): 24-26 February 2016
European Medicines Agency, London, UK, from 24/02/2016 to 26/02/2016, Last updated: 24/02/2016 -
List item
PRAC: meeting archive 2012-2013
Last updated: 13/05/2016 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2015
European Medicines Agency, London, UK, from 07/04/2015 to 10/04/2015, Last updated: 20/05/201514 4.1.3. Sitagliptin - JANUVIA (CAP), RISTABEN … TESAVEL (CAP), XELEVIA (CAP) Sitagliptin, metformin hydrochloride … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 April 2018
European Medicines Agency, London, UK, from 09/04/2018 to 12/04/2018, Last updated: 13/03/2014 -
List item
Paediatric Committee (PDCO): 30 March – 1 April 2016
European Medicines Agency, London, UK, from 30/03/2016 to 01/04/2016, Last updated: 30/06/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 May 2014
European Medicines Agency, London, UK, from 05/05/2014 to 08/05/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 September 2018
European Medicines Agency, London, UK, from 03/09/2018 to 06/09/2018, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 July 2013
European Medicines Agency, London, UK, from 08/07/2013 to 11/07/2013, Last updated: 02/07/2012